Tomer Bronshtein

940 total citations
20 papers, 763 citations indexed

About

Tomer Bronshtein is a scholar working on Biomaterials, Surgery and Molecular Biology. According to data from OpenAlex, Tomer Bronshtein has authored 20 papers receiving a total of 763 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Biomaterials, 11 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Tomer Bronshtein's work include Tissue Engineering and Regenerative Medicine (10 papers), Electrospun Nanofibers in Biomedical Applications (9 papers) and Mesenchymal stem cell research (4 papers). Tomer Bronshtein is often cited by papers focused on Tissue Engineering and Regenerative Medicine (10 papers), Electrospun Nanofibers in Biomedical Applications (9 papers) and Mesenchymal stem cell research (4 papers). Tomer Bronshtein collaborates with scholars based in Israel, Singapore and United States. Tomer Bronshtein's co-authors include Marcelle Machluf, Limor Baruch, Yael Lupu‐Haber, Limor Kaneti, Naama E. Toledano Furman, Udi Sarig, Subbu S. Venkatraman, Nitsan Dahan, Yao Wang and Galoz Kaneti and has published in prestigious journals such as Nano Letters, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Tomer Bronshtein

19 papers receiving 753 citations

Peers

Tomer Bronshtein
Comparison fields: 5 of 68
  • Biomaterials 375
  • Molecular Biology 326
  • Biomedical Engineering 321
  • Surgery 217
  • Genetics 90
Xichao Zhou China
Yanmeng Wang China
Bolei Cai China
Shengwei Han China
Simon Pascual‐Gil Spain
Drew Kuraitis Canada
Catarina Leite Pereira Portugal
Jie Zou China
Zhaobo Fan United States
Yonghuan Zhen China
Xichao Zhou China View profile →
Citations per field, relative to Tomer Bronshtein
Tomer Bronshtein · 1×
Citations per year, relative to Tomer Bronshtein
Tomer Bronshtein · 1×

Countries citing papers authored by Tomer Bronshtein

Since Specialization
Citations

This map shows the geographic impact of Tomer Bronshtein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomer Bronshtein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomer Bronshtein more than expected).

Fields of papers citing papers by Tomer Bronshtein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomer Bronshtein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomer Bronshtein. The network helps show where Tomer Bronshtein may publish in the future.

Co-authorship network of co-authors of Tomer Bronshtein

This figure shows the co-authorship network connecting the top 25 collaborators of Tomer Bronshtein. A scholar is included among the top collaborators of Tomer Bronshtein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomer Bronshtein. Tomer Bronshtein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Therapeutic Potential and Mechanisms of Mesenchymal Stem Cells in Coronary Artery Disease: Narrative Review International Journal of Molecular Sciences Tejas Patel, Tomer Bronshtein et al. 1
2 ADVANCING MESENCHYMAL CELL-BASED BONE TISSUE ENGINEERING: COMPREHENSIVE PHASE II CLINICAL TRIAL OUTCOMES OF BONOFILL™ IN MAXILLOFACIAL RECONSTRUCTION Cytotherapy Nimrod Rozen, Atara Novak et al. 0
3 Extracellular Vesicles Reflect the Efficacy of Wheatgrass Juice Supplement in Colon Cancer Patients During Adjuvant Chemotherapy Frontiers in Oncology Miri Cohen, Benjamin Brenner et al. 21
4 Pretreating Mesenchymal Stem Cells with Cancer Conditioned‐Media or Proinflammatory Cytokines Changes the Tumor and Immune Targeting by Nanoghosts Derived from these Cells Advanced Healthcare Materials Yael Lupu‐Haber, Tomer Bronshtein et al. 9
5 Therapy-Educated Mesenchymal Stem Cells Enrich for Tumor-Initiating Cells Cancer Research Michael Timaner, Madeleine Benguigui et al. 83
6 Radiolabeling of cell membrane-based nano-vesicles with 14C-linoleic acid for robust and sensitive quantification of their biodistribution Journal of Controlled Release Galoz Kaneti, Tomer Bronshtein et al. 14
7 Restoring the biophysical properties of decellularized patches through recellularization Biomaterials Science Udi Sarig, Hadar Sarig et al. 17
8 Dynamic Autologous Reendothelialization of Small-Caliber Arterial Extracellular Matrix: A Preclinical Large Animal Study Tissue Engineering Part A Nitsan Dahan, Udi Sarig et al. 54
9 PLGA-Listeriolysin O microspheres: Opening the gate for cytosolic delivery of cancer antigens Biomedical Microdevices Limor Baruch, Tomer Bronshtein et al. 4
10 Nanoghosts as a Novel Natural Nonviral Gene Delivery Platform Safely Targeting Multiple Cancers Nano Letters Limor Kaneti, Tomer Bronshtein et al. 92
11 Pushing the Envelope in Tissue Engineering: Ex Vivo Production of Thick Vascularized Cardiac Extracellular Matrix Constructs Tissue Engineering Part A Udi Sarig, Yao Wang et al. 36
12 The effect of AZD2171- or sTRAIL/Apo2L-loaded polylactic-co-glycolic acid microspheres on a subcutaneous glioblastoma model Biomedical Microdevices Tomer Bronshtein, Tom Haber et al. 8
13 Characterization of a bioactive fiber scaffold with entrapped HUVECs in coaxial electrospun core-shell fiber PubMed Hui Ying Ang, Scott A. Irvine et al. 17
14 Reconstructed Stem Cell Nanoghosts: A Natural Tumor Targeting Platform Nano Letters Naama E. Toledano Furman, Yael Lupu‐Haber et al. 224
15 A Mathematical Model for Analyzing the Elasticity, Viscosity, and Failure of Soft Tissue: Comparison of Native and Decellularized Porcine Cardiac Extracellular Matrix for Tissue Engineering Tissue Engineering Part C Methods Tomer Bronshtein, Udi Sarig et al. 24
16 A Mathematical Model Predicting the Coculture Dynamics of Endothelial and Mesenchymal Stem Cells for Tissue Regeneration Tissue Engineering Part A Yao Wang, Tomer Bronshtein et al. 6
17 Thick Acellular Heart Extracellular Matrix with Inherent Vasculature: A Potential Platform for Myocardial Tissue Regeneration Tissue Engineering Part A Udi Sarig, Yao Wang et al. 70
18 Endothelialization of Acellular Porcine ECM with Chemical Modification International Journal of Bioscience Biochemistry and Bioinformatics Yao Wang, Tomer Bronshtein et al. 7
19 Cell derived liposomes expressing CCR5 as a new targeted drug-delivery system for HIV infected cells Journal of Controlled Release Tomer Bronshtein, Naama E. Toledano Furman et al. 41
20 Development of ALS-like disease in SOD-1 mice deficient of B lymphocytes Journal of Neurology Keren Zohar, Tomer Bronshtein et al. 35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026